| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following securities, presented on a common stock equivalent basis, have been excluded from the calculation of weighted-average number of shares of common stock outstanding because their effect is anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Awards under equity incentive plans | | 2,691,729 | | 2,740,278 | | 2,691,729 | | 2,740,278 | | Common stock warrants | | — | | — | | — | | — | | Total securities excluded from the calculation of weighted average number of shares of common stock outstanding | | 2,691,729 | | 2,740,278 | | 2,691,729 | | 2,740,278 |
|
| Schedule of Earnings Per Share, Basic and Diluted |
A reconciliation from net income to basic net income attributable to common stockholders per share of common stock and diluted net income attributable to common stockholders per share of common stock for the three and six months ended June 30, 2026, and 2025 is as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Basic net income per share of common stock: | | | | | | | | | | Net income | | $ | 8,752 | | | $ | 74,707 | | | $ | 46,642 | | | $ | 71,608 | | | Earnings allocated to participating securities | | (359) | | | (6,798) | | | (1,924) | | | (6,552) | | | Net income attributable to shares of common stock | | 8,393 | | | 67,909 | | | 44,718 | | | 65,056 | | | Less: Dividends declared or accumulated | | — | | | — | | | — | | | — | | | Undistributed net income attributable to shares of common stock, basic | | 8,393 | | | 67,909 | | | 44,718 | | | 65,056 | | | Weighted-average shares of common stock outstanding | | 59,156 | | | 54,781 | | | 58,783 | | | 54,440 | | | Basic net income per share of common stock | | $ | 0.14 | | | $ | 1.24 | | | $ | 0.76 | | | $ | 1.20 | | | | | | | | | | | | Diluted net income per share of common stock: | | | | | | | | | | Net income attributable to shares of common stock | | $ | 8,393 | | | $ | 67,909 | | | $ | 44,718 | | | $ | 65,056 | | | Plus: Fair value adjustment income related to warrant liability | | — | | | — | | | — | | | — | | | Net income attributable to shares of common stock, diluted | | 8,393 | | | 67,909 | | | 44,718 | | | 65,056 | | | Weighted-average number of shares of common stock outstanding | | 59,156 | | | 54,781 | | | 58,783 | | | 54,440 | | | Dilutive effect of outstanding stock options (as converted to common stock) | | 2,181 | | | 1,544 | | | 2,003 | | | 1,622 | | | Weighted-average shares of common stock outstanding, diluted | | 61,337 | | | 56,325 | | | 60,786 | | | 56,062 | | | Diluted net income per share of common stock | | $ | 0.14 | | | $ | 1.21 | | | $ | 0.74 | | | $ | 1.16 | |
|